Literature DB >> 15989711

Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report.

Sattva S Neelapu1, Barry L Gause, Daniel A Nikcevich, Stephen J Schuster, Jane Winter, Jon P Gockerman, Thomas Loughran, Ken Takeshita, Giorgio Inghirami, Dean McGaughey, Thelma M Watson, Sandra Snow, Paula Kubovic, Miriam Ferraro, Elizabeth Jones, Elaine S Jaffe, Douglas J Schwartzentruber, David Danforth, Richard Sherry, Erik Kass, Carter Van Waes, Craig W Reynolds, Larry J Kwak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15989711     DOI： 10.3816/clm.2005.n.031

Source DB:  PubMed          Journal:  Clin Lymphoma        ISSN： 1526-9655


× No keyword cloud information.
  8 in total

Review 1.  Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials.

Authors:  Hyun Jun Park; Sattva S Neelapu
Journal:  Br J Haematol       Date:  2008-04-13       Impact factor: 6.998

2.  Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.

Authors:  Susana Inoges; Ascension Lopez-Diaz de Cerio; Helena Villanueva; Fernando Pastor; Elena Soria; Maurizio Bendandi
Journal:  World J Clin Oncol       Date:  2011-06-10

3.  The role of novel immunotherapies in non-Hodgkin lymphoma.

Authors:  Allyson Pishko; Sunita D Nasta
Journal:  Transl Cancer Res       Date:  2017-02       Impact factor: 1.241

Review 4.  Immune microenvironments in solid tumors: new targets for therapy.

Authors:  Stephen L Shiao; A Preethi Ganesan; Hope S Rugo; Lisa M Coussens
Journal:  Genes Dev       Date:  2011-12-15       Impact factor: 11.361

5.  Construction, expression and in vitro biological effects of idiotype Ig Fab fragment of B-chronic lymphocytic leukemia.

Authors:  Feng Wang; Ping Lei; Ping Hu; Lijuan Zhu; Huifeng Zhu; Yue Zhang; Jing Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

Review 6.  The immune response to tumors as a tool toward immunotherapy.

Authors:  F Pandolfi; R Cianci; D Pagliari; F Casciano; C Bagalà; A Astone; R Landolfi; C Barone
Journal:  Clin Dev Immunol       Date:  2011-12-05

7.  B-cell lymphomas present immunoglobulin neoantigens.

Authors:  Michael S Khodadoust; Niclas Olsson; Binbin Chen; Brian Sworder; Tanaya Shree; Chih Long Liu; Lichao Zhang; Debra K Czerwinski; Mark M Davis; Ronald Levy; Joshua E Elias; Ash A Alizadeh
Journal:  Blood       Date:  2018-12-13       Impact factor: 25.476

Review 8.  Therapeutic vaccine for lymphoma.

Authors:  Seung-Tae Lee; Sattva S Neelapu; Larry W Kwak
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.